Alessandro Riva is Director of BeiGene, Ltd.. Currently has a direct ownership of 45,955 shares of BGNE, which is worth approximately $8.75 Million. The most recent transaction as insider was on Jun 05, 2024, when has been sold 16,341 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 46K
0% 3M change
55.18% 12M change
Total Value Held $8.75 Million

Alessandro Riva Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 05 2024
BUY
Grant, award, or other acquisition
-
16,341 Added 26.23%
45,955 Ordinary Shares
Jun 15 2023
BUY
Grant, award, or other acquisition
-
12,922 Added 30.38%
29,614 Ordinary Shares
Jun 22 2022
BUY
Grant, award, or other acquisition
-
16,692 Added 50.0%
16,692 Ordinary Shares

Also insider at

IPSC
Century Therapeutics, Inc. Healthcare
AR

Alessandro Riva

Director
Grand Cayman, E9

Track Institutional and Insider Activities on BGNE

Follow BeiGene, Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BGNE shares.

Notify only if

Insider Trading

Get notified when an Bei Gene, Ltd. insider buys or sells BGNE shares.

Notify only if

News

Receive news related to BeiGene, Ltd.

Track Activities on BGNE